Explore. Learn. Join the conversation.

Working Group on New TB Drugs

Stop TB Partnership

26 Apr 2013
by Working Group

Posted in Announcements, TB Drug Development, TB Pediatrics

Tagline Spring 2013: 3 Articles on TB Research


Treatment Action Group (TAG) recently released its Spring 2013 issue of tagline, which contains three articles about TB research that might be of interest to you– 1) on rifapentine research and access, 2) on adaptive clinical trial designs, and 3) on pediatric drug development needs.

16 Apr 2013
by Working Group

Posted in Announcements, market access, TB News

New Database Tracks Health Technology Innovations

Click here to check out entire database.

The Center for Health Market Innovations (CHMI) has compiled profiles on over 1,200 programs and counting. For TB innovations, the CHMI database contains 58 programs that work on TB in 33 countries.

Get Ready for World TB Day March 24, 2013!

WTBD 2013

World TB Day is celebrated on March 24 and there is a lot going on during this week and next to highlight the continued problem of TB in the world and the solutions to address the problem. Included is a list of publications, news items, events, and links related to TB and World TB Day 2013.

Bedaquiline Receives Accelerated Approval from the FDA for MDR-TB Rx


The FDA granted Janssen’s TB drug Bedaquiline accelerated approval for treatment of MDR-TB. A link is provided to the FDA press release and Janssen’s full press release is included.

17 Oct 2012
by Working Group

Posted in Action, Announcements, TB News

WHO Releases Global Tuberculosis Report 2012


The WHO released the Global Tuberculosis Report 2012 today. The main highlights and additional coverage are included.

Immunotherapeutic Vaccines, TB and China: Interview with Dr. Douglas Lowrie


This week we highlight an interview with Dr. Douglas Lowrie, a Senior Research Fellow at Fudan University’s Shanghai Public Health Clinical Center in China. He discusses the extent of the problem of TB in China and innovative research on enhancing TB treatment using immunotherapeutic vaccines.

4 Sep 2012
by Working Group

Posted in Front Lines of TB R&D, TB News, TB Treatment

TB R&D Weekly Update: High Dose Vitamin D May Enhance TB Treatment


This week we highlight a study showing promising results that providing high dose vitamin D supplements along with antibiotics could improve treatment outcomes for TB patients. The abstract and additional news coverage are included, as well as, links to other TB R&D news.

15 Aug 2012

2012 WGND Annual Meeting is Nov 14 in Kuala Lumpur

2010 Annual Meeting

We will have our 2012 Annual Meeting in Kuala, Lumpur on Wednesday, November 14 at the Impiana KLCC Hotel from 13:00 to 17:30. The meeting will be held in conjunction with the 43rd Union World Conference on Lung Health.

24 Jul 2012
by Working Group

Posted in Announcements, TB Drug Development, TB News, Video

TB R&D Weekly Update: Results from First Novel Regimen Trial Published

novel regimen video

Yesterday, efficacy data from the first novel regimen trial (NC001) were published in the Lancet. The results found that the regimen containing PA-824, moxifloxacin, and pyrazinamide, could kill more than 99 percent of patients’ TB bacteria within two weeks and could be more effective than existing treatments. Link to article, press release, and related video are included. Additional links to TB R&D news are also included.

Call for TB REACH Wave 3 Proposals


TB REACH is currently accepting applications for Wave 3. The deadline for submitting proposals for Wave 3 is 17 September 2012.